The Utility of HPV In Situ Hybridization and the PAS Test in Improving the Specificity of the Diagnosis of CIN 1

dc.TypeArticlept_BR
dc.contributor.authorMacedo, Fabiane Carvalho de
dc.contributor.authorNicol, Alcina Frederica
dc.contributor.authorScudeler, Donizete
dc.contributor.authorNuovo, Gerard
dc.date.accessioned2022-01-31T17:01:04Z
dc.date.available2022-01-31T17:01:04Z
dc.date.issued2009
dc.descriptionp. 83-89.: il. color.
dc.description.abstractThe histologic features of cervical intraepithelial neoplasia (CIN 1), caused by infection by the human papillomavirus (HPV), can overlap with those of its mimics that can lead to an over diagnosis of this sexually transmitted disease. In this study, 67 consecutive cervical biopsies that were diagnosed as CIN 1 from the surgical files of Ohio State University Medical Center were analyzed. Twenty controls (10 CIN 1 cervical biopsies and 10 normal cervical tissues) were also studied. The 87 biopsies were reevaluated blinded to the original diagnosis and the results were correlated with detection of HPV DNA by in situ hybridization and glycogen by the periodic acid solution (PAS)/PAS-D stain, respectively. HPV was detected by in situ hybridization in 55/67 cases (82%); no virus was evident in the negative controls whereas each of the 10 CIN 1 controls was virus positive. A PAS test demonstrated in the mature squamous component of the negative controls a strong signal in cells with prominent and uniform halos, which was lost with diastase treatment, indicative of abundant glycogen. The PAS/PAS-D tests in the CIN 1 lesions showed rare variable sized glycogen deposits in the dysplastic cells. Nine (15%) cases initially diagnosed as CIN 1 were HPV negative by in situ hybridization and had halolike cells that were strongly and uniformly positive for glycogen. This data underscores the value of glycogen and HPV analyses in improving the specificity of the diagnosis of CIN 1.
dc.identifier.citationMACEDO, Fabiane Carvalho de et al. The Utility of HPV In Situ Hybridization and the PAS Test in Improving the Specificity of the Diagnosis of CIN 1. Int J Gynecol Pathol., v. 28, n. 1, p. 83-89, jan. 2009.
dc.identifier.issn1538-7151
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/4990
dc.publisherInt J Gynecol Pathol,pt_BR
dc.subjectHibridização In Situpt_BR
dc.subjectIn Situ Hybridizationpt_BR
dc.subjectGlicogêniopt_BR
dc.subjectGlycogenpt_BR
dc.subjectHumanospt_BR
dc.subjectHumanspt_BR
dc.subjectPapillomaviridaept_BR
dc.subjectSilibinapt_BR
dc.subjectSilybinpt_BR
dc.titleThe Utility of HPV In Situ Hybridization and the PAS Test in Improving the Specificity of the Diagnosis of CIN 1pt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The_Utility_of_HPV_In_Situ_Hybridization_and_the.13 (1).pdf
Size:
441.69 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: